Effects of Salinomycin and 17‑AAG on Proliferation of Human Gastric Cancer Cells In vitro

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2017 Jun 20

PMID 28627587

Authors

Zuwen Zhang

Jumei Zhao

Zhikuan Mi

Qiuxia Pang

Aihong Wang

Meini Chen

Xiaobin Liu

Xiaoli Wei

Tao Liu

Affiliations

Soon will be listed here.

Abstract

The aim of the present study was to investigate the effects and mechanisms of 17‑AAG combined with salinomycin treatment on proliferation and apoptosis of the SGC‑7901 gastric cancer cell line. An MTT assay was used to detect the proliferation of SGC‑7901 cells. Morphological alterations of cells were observed under inverted phase‑contrast and fluorescence microscopes. Cell cycle and apoptosis were assessed by flow cytometry analysis. The protein expression of nuclear factor (NF)‑κB p65 and Fas‑ligand (L) were evaluated by immunocytochemistry. Salinomycin with a concentration range of 1‑32 µmol/l was demonstrated to inhibit growth of SGC‑7901 cells effectively, affect the morphology and apoptosis rate of cells, and arrest SGC‑7901 cells in S phase. Furthermore, salinomycin significantly increased the protein expression of Fas‑L and decreased the protein expression of NF‑κB p65. The alterations in SGC‑7901 cells co‑treated with salinomycin and 17‑AAG were more significant compared with cells treated with one drug only. In conclusion, the individual use of salinomycin and combined use with 17‑AAG may significantly inhibit SGC‑7901 gastric cancer cell proliferation and induce cell apoptosis. The potential mechanisms may be associated with upregulation of Fas‑L and downregulation of NF‑κB. These results provide a basis for the potential use of salinomycin in gastric cancer treatment.

References

Cai Z, Tchou-Wong K, Rom W . NF-kappaB in lung tumorigenesis. Cancers (Basel). 2013; 3(4):4258-68. PMC: 3763422. DOI: 10.3390/cancers3044258. View

Zhang Y, Zuo Y, Guan Z, Lu W, Xu Z, Zhang H . Salinomycin radiosensitizes human nasopharyngeal carcinoma cell line CNE-2 to radiation. Tumour Biol. 2015; 37(1):305-11. DOI: 10.1007/s13277-015-3730-6. View

Chen S, Chen X, Li Y, Yang S, Mo X, Zhang F . [Inhibitory effect of 17-AAG combined with paclitaxel on proliferation of esophageal squamous cell carcinoma Eca-109 cells in vitro]. Nan Fang Yi Ke Da Xue Xue Bao. 2015; 35(6):844-7. View

Wu G, Pan C, Jiang D, Zhang Q, Li Y, Zheng S . Clinicopathological significance of Fas and Fas ligand expressions in esophageal cancer. Am J Cancer Res. 2015; 5(9):2865-71. PMC: 4633913. View

Kopp F, Hermawan A, Oak P, Ulaganathan V, Herrmann A, Elnikhely N . Sequential Salinomycin Treatment Results in Resistance Formation through Clonal Selection of Epithelial-Like Tumor Cells. Transl Oncol. 2014; 7(6):702-11. PMC: 4311025. DOI: 10.1016/j.tranon.2014.09.002. View

Xu W, Yang Z, Lu N . Molecular targeted therapy for the treatment of gastric cancer. J Exp Clin Cancer Res. 2016; 35:1. PMC: 4700735. DOI: 10.1186/s13046-015-0276-9. View

Boehmerle W, Muenzfeld H, Springer A, Huehnchen P, Endres M . Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice. J Mol Med (Berl). 2014; 92(8):889-900. DOI: 10.1007/s00109-014-1155-0. View

Xiao Z, Sperl B, Ullrich A, Knyazev P . Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status. Oncotarget. 2014; 5(24):12877-90. PMC: 4350329. DOI: 10.18632/oncotarget.2657. View

Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L . Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res. 2013; 25(1):10-21. PMC: 3555299. DOI: 10.3978/j.issn.1000-9604.2012.12.04. View

10.

Kim J, Chae M, Kim W, Kim Y, Kang H, Kim H . Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein. Br J Pharmacol. 2010; 162(3):773-84. PMC: 3041264. DOI: 10.1111/j.1476-5381.2010.01089.x. View

11.

Zhi Q, Chen X, Ji J, Zhang J, Li J, Cai Q . Salinomycin can effectively kill ALDH(high) stem-like cells on gastric cancer. Biomed Pharmacother. 2011; 65(7):509-15. DOI: 10.1016/j.biopha.2011.06.006. View

12.

Niccolai E, Taddei A, Prisco D, Amedei A . Gastric cancer and the epoch of immunotherapy approaches. World J Gastroenterol. 2015; 21(19):5778-93. PMC: 4438012. DOI: 10.3748/wjg.v21.i19.5778. View

13.

Xu Y, Zhu Q, Chen D, Shen Z, Wang W, Ning G . The HSP90 inhibitor 17-AAG exhibits potent antitumor activity for pheochromocytoma in a xenograft model. Tumour Biol. 2015; 36(7):5103-8. DOI: 10.1007/s13277-015-3162-3. View

14.

Schulte T, Neckers L . The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin. Cancer Chemother Pharmacol. 1998; 42(4):273-9. DOI: 10.1007/s002800050817. View

15.

Gupta P, Onder T, Jiang G, Tao K, Kuperwasser C, Weinberg R . Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009; 138(4):645-659. PMC: 4892125. DOI: 10.1016/j.cell.2009.06.034. View

16.

Kim S, Kang J, Kim C, Ihm S, Choi M, Yoo H . 17-Allylamino-17-demethoxygeldanamycin and Herbimycin A Induce Cell Death by Modulating β-Catenin and PI3K/AKT Signaling in FRO Anaplastic Thyroid Carcinoma Cells. Anticancer Res. 2015; 35(10):5453-60. View

17.

Diab S, Fidanzi C, Leger D, Ghezali L, Millot M, Martin F . Berberis libanotica extract targets NF-κB/COX-2, PI3K/Akt and mitochondrial/caspase signalling to induce human erythroleukemia cell apoptosis. Int J Oncol. 2015; 47(1):220-30. DOI: 10.3892/ijo.2015.3012. View

18.

Wang Y, Wang C, Jiang C, Zeng H, He X . Novel mechanism of harmaline on inducing G2/M cell cycle arrest and apoptosis by up-regulating Fas/FasL in SGC-7901 cells. Sci Rep. 2015; 5:18613. PMC: 4683523. DOI: 10.1038/srep18613. View

19.

Liu W, Lin Y, Yan X, Ding Y, Wu Y, Chen W . Hepatitis B virus core protein inhibits Fas-mediated apoptosis of hepatoma cells via regulation of mFas/FasL and sFas expression. FASEB J. 2014; 29(3):1113-23. DOI: 10.1096/fj.14-263822. View

20.

Miyazaki Y, Shibuya M, Sugawara H, Kawaguchi O, Hirsoe C . Salinomycin, a new polyether antibiotic. J Antibiot (Tokyo). 1974; 27(11):814-21. DOI: 10.7164/antibiotics.27.814. View